Regeneron PharmaceuticalsREGN 
$1,162.002.04%24h
2.04%24h
Global rank111
Market cap$124.48B
Change 7d-0.00%
YTD Performance32.97%
SP500 benchmarkOutperform
P/E0
P/S9.49
Revenue$13.12B
Earnings$3.95B
Dividend yield-
Main Sector
Healthcare
Regeneron Pharmaceuticals (REGN) Cash on Hand
REGN Cash on Hand in 2022: $10.84B
According to Regeneron Pharmaceuticals latest financial reports the cash on hand of REGN is $10.84B, an increase of 40.07% to 2022. At the end of 2022 company had $7.74B cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
REGN Cash on Hand History from 2018 to 2023
-
Value:-
REGN Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $10.84B | 40.07% |
| 2022 | $7.74B | 35.96% |
| 2021 | $5.69B | 58.76% |
| 2020 | $3.59B | 11.60% |
| 2019 | $3.21B | 14.39% |
| 2018 | $2.81B | - |
View the Top Cash on Hand Companies 
